Wilmington, Del.-based Integrity Applications completed a private placement offering, bringing in $12 million in total proceeds. The company, which makes the GlucoTrack non-invasive glucose measuring device, has been using the capital to support commercialization of the device in Europe and accelerate its regulatory and clinical efforts in China and the US.
Integrity Applications obtains $12M in private placement
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.